Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fabienne Foster‐Witassek"'
Autor:
Fabio Barresi, Fabienne Foster-Witassek, Hans Rickli, Giovanni Pedrazzini, Marco Roffi, Milo Puhan, Holger Dressel, Dragana Radovanovic
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract This study aimed to examine whether acute myocardial infarction (AMI) patients in Switzerland return to work and identify factors associated therewith. Data of 4315 working-age AMI patients enrolled in the Swiss AMIS Plus registry between 01
Externí odkaz:
https://doaj.org/article/b973f10def654e4fb9bd972bf93c39b5
Autor:
Stefanie Aeschbacher, David Conen, Stefan Osswald, Andreas Mueller, Tobias Reichlin, Christian Sticherling, Michael Kuhne, Matthias Schwenkglenks, Eva Blozik, Nicolas Rodondi, Giorgio Moschovitis, Carola A Huber, Michael Coslovsky, Marcello Di Valentino, Thomas D Szucs, Maria Luisa De Perna, Giulio Conte, Juerg H Beer, Miquel Serra-Burriel, Leo Bonati, Manuel Blum, Helena Aebersold, Stefan Felder, Rebecca E Paladini, Annina Stauber, Fabienne Foster-Witassek
Publikováno v:
Open Heart, Vol 11, Iss 1 (2024)
Aims Direct-acting oral anticoagulants (DOACs) have, to a substantial degree, replaced vitamin K antagonists (VKA) as treatments for stroke prevention in atrial fibrillation (AF) patients. However, evidence on the real-world causal effects of switchi
Externí odkaz:
https://doaj.org/article/2253404381524fd9b4706050f2f4dd24
Autor:
Fabienne Foster‐Witassek, Helena Aebersold, Stefanie Aeschbacher, Peter Ammann, Jürg H. Beer, Eva Blozik, Leo H. Bonati, Mattia Cattaneo, Michael Coslovsky, Stefan Felder, Giorgio Moschovitis, Andreas Müller, Seraina Netzer, Rebecca E. Paladini, Tobias Reichlin, Nicolas Rodondi, Annina Stauber, Christian Sticherling, Thomas Szucs, David Conen, Michael Kühne, Stefan Osswald, Miquel Serra‐Burriel, Matthias Schwenkglenks
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 21 (2023)
Background Optimizing health‐related quality of life (HRQoL) is an important aim of atrial fibrillation (AF) treatment. Little is known about patients' long‐term HRQoL trajectories and the impact of patient and disease characteristics. The aim of
Externí odkaz:
https://doaj.org/article/7b819097434143de811fef58b32c4553
Autor:
Stefanie Aeschbacher, David Conen, Stefan Osswald, Andreas Mueller, Tobias Reichlin, Christian Sticherling, Matthias Schwenkglenks, Eva Blozik, Beat Brüngger, Nicolas Rodondi, Michael Kuehne, Giorgio Moschovitis, Jürg-Hans Beer, Giulio Conte, Anne Springer, Miquel Serra-Burriel, Leo Bonati, Manuel Blum, Thomas Szucs, Helena Aebersold, Stefan Felder, Rebecca E Paladini, Annina Stauber, Fabienne Foster-Witassek, Carola Huber
Publikováno v:
BMJ Open, Vol 13, Iss 9 (2023)
Aims Atrial fibrillation (AF) costs are expected to be substantial, but cost comparisons with the general population are scarce. Using data from the prospective Swiss-AF cohort study and population-based controls, we estimated the impact of AF on dir
Externí odkaz:
https://doaj.org/article/a881604613cd4f0bba85847f90fcada7
Autor:
Luigi Biasco, Fabienne Foster-Witassek, Dragana Radovanovic, Philip Dittli, Gregorio Tersalvi, Hans Rickli, Marco Roffi, Franz Eberli, Raban Jeger, Paul Erne, Giovanni Pedrazzini
Publikováno v:
Revista Española de Cardiología.
Autor:
Luigi Biasco, Fabienne Foster-Witassek, Dragana Radovanovic, Philip Dittli, Gregorio Tersalvi, Hans Rickli, Marco Roffi, Franz Eberli, Raban Jeger, Paul Erne, Giovanni Pedrazzini
Publikováno v:
Revista Española de Cardiología (English Edition).